Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 172Gynecologic 18Thoracic 12Head & Neck 7Genitourinary 6Breast 6Sarcoma 5Dermatologic 4Other solid neoplasm 2Plasma cell 1Myeloid 1Endocrine 1CNS 1

Conditions

Carcinoma, Neuroendocrine 12Adrenocortical Carcinoma 9Neuroendocrine Tumors 5Small Cell Lung Carcinoma 4Thyroid Carcinoma, Anaplastic 3Peritoneal Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Somatostatinoma 2Sarcoma 2Neoplasms 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Small Cell 2Wilms Tumor 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Rhabdomyosarcoma 1Retroperitoneal Neoplasms 1Pheochromocytoma 1Ovarian Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroendocrine Neoplasms 1Neuroblastoma 1Mesothelioma, Malignant 1Medulloblastoma 1Lung Neoplasms 1Liver Neoplasms 1

Interventions

Trastuzumab 2Quality of Life 2Fluorodeoxyglucose F18 2tislelizumab 1tipifarnib 1surufatinib 1regorafenib 1milademetan 1lutetium Lu 177 dotatate 1fludarabine phosphate 1fludarabine 1entinostat 1copper dotatate CU-64 1Surveys and Questionnaires 1Ritonavir 1Radiotherapy 1Poly(ADP-ribose) Polymerase Inhibitors 1Patient Reported Outcome Measures 1PM 01183 1Oxaliplatin 1N-Ac-CHAVC-NH2 1Molecular Diagnostic Techniques 1Melphalan 1Magnetic Resonance Spectroscopy 1Lutetium-177 1Lutetium 1Leucovorin 1Irinotecan 1Interleukin-12 Subunit p35 1Interleukin-12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Cisplatin × Endocrine × Clear all
NCT00178698 2011-03-03

FR-WB-TT/che

The University of Texas Health Science Center, Houston

Phase 2 Unknown
36 enrolled
EndocrineGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡